Mike Milken speaks with Alex Gorsky, chairman and CEO of Johnson & Johnson. On March 30, 2020, Johnson & Johnson and the Biomedical Advanced Research and Development Authority (BARDA) announced a $1 billion partnership to accelerate testing of a lead vaccine candidate for COVID-19. Alex shares about Johnson & Johnson’s efforts to rapidly scale the company’s manufacturing capacity to supply one billion vaccines worldwide for emergency pandemic use in 2021—and to do so on a nonprofit basis so the vaccine is affordable and widely available.

https://milkeninstitute.org/podcast